The European Molecular Biology Organization (EMBO) announced that thirty life scientists have been selected as EMBO Young Investigators. Amongst them is Christoph Zechner, research group leader at the CSBD and the Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG). He joins 73 current and 384 former members of the Young Investigators program, which is designed for young researchers under the age of 40, within their first four years of being principal investigators, and who have a proven record of scientific excellence.
As part of the Young Investigator Program, Christoph Zechner has access to a wide range of benefits including networking opportunities, training in leadership skills and responsible research practices, and access to core facilities at the European Molecular Biology Laboratory (EMBL). Young Investigators receive an award of 15,000 euros in the second year of their tenure and can apply for further funding, travel grants, and take advantage of mentorship opportunities among many other benefits.
Christoph Zechner’s research group uses theoretical approaches to study stochastic processes in cells and tissues. “Many biochemical processes involve a substantial amount of randomness. We want to understand how biological systems function reliably despite random fluctuations.”
EMBO is an organization of more than 1800 leading researchers that promotes excellence in the life sciences in Europe and beyond. It directs funding from member states towards research fellowships, courses, workshops, conferences, and science policy initiatives. EMBO also has a stable of prestigious life science journals. The administrative headquarters is in Heidelberg, Germany.
EMBO Press Release